Navigation Links
Apolipoprotein(a): A natural regulator of inflammation
Date:12/24/2008

In a study to be published in the January 09 issue of Experimental Biology and Medicine, Hoover-Plow and co-workers in seeking to define a role of apo(a) in leukocyte recruitment have identified a novel activity of apo(a) apolipoprotein that may function as a natural and cell specific suppressor of the inflammatory response in vivo. In addition, a mechanism for this novel function of apo(a) was also identified: its selective regulation of cytokine production. These effects of apo(a) are independent of its molecular mimicry of Plg.

Lipoprotein(a) (Lp(a)) is similar to low density lipoprotein (LDL), but contains an additional apolipoprotein, apo(a). Numerous clinical studies conducted over the past 40 years have identified Lp(a) as a risk factor independent from LDL for a variety of cardiovascular pathologies. Much of the focus of apo(a) pathogenic activities has centered on its strong resemblance to plasminogen, the zymogen for plasmin, the primary enzyme for blood clot degradation. In addition to its important role in clot lysis, plasmin is required for leukocyte recruitment in inflammation. While several in vitro studies have demonstrated the interference of apo(a) in plasminogen leukocyte recruitment, evidence for this in vivo has been lacking.

In vivo investigation of Lp(a) function has been impeded by the lack of availability of small animal models. Lp(a) is expressed only in humans, nonhuman primates and the European hedgehog. In this study Hoover-Plow's group utilized mice with apo(a) in a plasminogen deficient or replete background to study leukocyte recruitment in three models of inflammation. Hoover-Plow said "In this study apo(a) impeded neutrophil recruitment in two of the models of inflammation, thioglycollate and lipopolysaccharide induced peritonitis. Apo(a) also inhibited neutrophil chemoattractants, and neutrophil recruitment was restored in mice administered neutrophil chemoattractants. The impaired neutrophil recruitment o
'/>"/>

Contact: Dr. Jane Hoover-Plow
hooverj@ccf.org
216-445-8207
Society for Experimental Biology and Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. New research shows how gene function drives natural selection in important class of genetic elements
2. Honey adds health benefits, is natural preservative and sweetener in salad dressings
3. Natural Capital Project to develop conservation software
4. Ecologists say metabolism accounts for why natural selection favors only some species
5. Natural and social sciences: ICSU embraces the need to work more closely together
6. International Council for Science launches major research program on natural disasters
7. Design of a compound that stabilizes the main natural suppressor of tumors
8. Discovery of natural compounds that could slow blood vessel growth
9. Natural childbirth linked to stronger baby bonding than C-sections
10. How plants fine tune their natural chemical defenses
11. Old before their time? Aging in flies under natural vs. laboratory conditions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...el Research Institute (VARI) researchers have dete...id (ABA) works at the molecular level to help plan...ht and cold. Their findings, published in the jou...ve in harsh environments around the world and comb... have implications for stress disorders in humans....
(Date:12/3/2009)...nge in warmer water, according to an intriguing ne...me species more aggressive. , Experiments with t...t Barrier Reef have shown for the first time that ...onsistently bold, and that these individual differ...ise. , A slight lift of just one or two degrees ...
(Date:12/3/2009)...nubbing? Your genetics, not your friends, may be a...-like painkillers, called opioids, relieve not onl...stress. Now, a new study reviewed by Faculty of 10...enetic differences in the gene for the opioid rece...nses to social rejection. , In the study publis...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Fish with attitude: Some like it hot 2eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 1eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 2eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 3Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17 2009 6162 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17 2009 6162 2Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 6159 1Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 6159 2
...p a clearer picture of what makes some people stan...earchers who last year identified the first common...tified a further twenty regions of the genome whic...cm. , The results, published together with two i...ure Genetics, mean that scientists now know of doz...
...s that desperately try to reach for a break in the...e same affliction: Shade avoidance syndrome or SAS...ght to light by researchers at the Salk Institute ...eighbors shade, plants switch on a natural chemica...rmone auxin that lets a plant grow and ultimately ...
...ute for Medical Research (Burnham) may have found ... showing the link between a certain protein and th...feed breast tumors. Like mortar between bricks in ...tick together and collectively form tissues. Cance...op producing T-cadherin, and in tumors, only the b...
Other Biology News:A tall story: New research adds to growing body of knowledge of genetics of height 2A place in the sun 2A place in the sun 3T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role 2T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role 3
(Date:12/3/2009)...NCISCO, Dec. 3 VIA Pharm... company focused on the development of compounds f...isease, today announced that it has completed the ... trial of VIA-2291. ,, The FDG-PET trial enrol...in the US and Canada including Massachusetts Gener...
(Date:12/3/2009)...LPHIA, Dec. 3 Shire plc ...biopharmaceutical company, today announced a volun...drawal of one lot of the Attention-Deficit/Hyperac...re is taking this action because some Daytrana pat...ir release liner removal specification, and as a r...
(Date:12/3/2009)...IN, Calif., Dec. 3 Pereg...announced that it will release its financial resul...ecember 10, 2009 at 7:00 a.m. EST and will host a ... at 11:30 a.m. EST on the same day. ,, Peregrin...ts for the second quarter ended October 31, 2009 a...
(Date:12/3/2009)..., Mass., Dec. 3 Invernes...al leader in enabling individuals to take charge o... diagnostics and health management, has declared a...rtible Perpetual Preferred Stock ( IMA-PB). The di... an amount per share equal to the quotient of (a) ...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2
...ovember 28, Evotec AG (Frankfurt Stock Exchange: E...laus Maleck have been appointed to,the Company,s M...icer and,Chief Financial Officer., Jorn Aldag, Pr...id:,"I,m extremely pleased to announce the additio...anagement Board. Both are individuals with a wealt...
...asdaq:,PPDI) today announced the appointment of Jo... clinical operations, to lead the company,s delive... America and the Caribbean.,Based in Mexico City, ...PPD,clinical services in the region., "Dr. Viramo...tical,industry in Mexico, extensive clinical resea...
...ceutical Company Inc. (Nasdaq: NSTK ) announced t...ts Focus on Healthcare Conference on,Wednesday, De...llennium,Broadway Hotel in New York City., To acc...ease log on to,Nastech,s website at http://www.na...resentation in order to register and download any ...
Other Biology Technology:Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board 2Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board 3Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board 4Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean 2Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean 3
...ti-purpose, high gel-strength agarose suitable for...m conventional constant field to Pulsed Field Gel ...th and exclusion limits, Multi ABgarose can effect...nning times. This in turn means reduced band diffu...
...is a molecular screening, low melting point agaros...g. It is recommended for separation of nucleic aci...icro ABgarose is also suited to capillary electrop...ques. At a 3% concentration, Micro ABgarose gels a...
Sheep Anti-Salmonella Shoreditch Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: